Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase III, noninferiority study

OBJECTIVE: To demonstrate the efficacy and safety of paliperidone palmitate three-monthly (PP3M) formulation in an East Asian population with schizophrenia by subgroup analysis of a double-blind (DB), multicenter, noninferiority study. PATIENTS AND METHODS: Of 1,429 patients who entered the open-lab...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuropsychiatr Dis Treat
Main Authors: Savitz, Adam J, Xu, Haiyan, Gopal, Srihari, Nuamah, Isaac, Ravenstijn, Paulien, Hough, David, Mathews, Maju, Feng, Yu, Yu, Lu, Takahashi, Masayoshi, Liu, Dennis, Wang, Gang, Yoon, Jin-Sang, Chen, Jiahn-Jyh
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2017
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5566420/
https://ncbi.nlm.nih.gov/pubmed/28860777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S134287
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares